Logotype for Merck KGaA

Merck (MRK) investor relations material

Merck Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Merck KGaA
Q3 2025 earnings summary13 Nov, 2025

Executive summary

  • Achieved solid organic growth across all three sectors in Q3 2025, with group revenues up 5.2% and EBITDA pre up 8.8% year-over-year, despite significant currency headwinds.

  • Life Science and Healthcare led growth, with Life Science organic sales up 6% and Healthcare benefiting from the SpringWorks acquisition.

  • SpringWorks acquisition consolidated for the first time, contributing to Healthcare growth and portfolio effects.

  • Major portfolio changes included the acquisition of SpringWorks Therapeutics and the divestment of the Surface Solutions business.

  • Full-year 2025 guidance confirmed and narrowed for net sales, EBITDA pre, and EPS pre, with midpoints maintained or slightly increased.

Financial highlights

  • Q3 2025 net sales rose 1% to €5,318 million; organic growth of €273 million offset by FX headwinds of €-256 million.

  • EBITDA pre increased 3.1% to €1,669 million, margin up to 31.4% year-over-year.

  • EPS pre up 0.9% to €2.32; reported EPS up 11.3% to €2.07.

  • Operating cash flow for Q3 2025 grew 4.1% to €1,518 million; net financial debt increased 29.8% to €9,288 million, mainly due to the SpringWorks acquisition.

  • EBIT up 11.3% year-over-year; financial result declined due to higher interest costs from new bond issuance.

Outlook and guidance

  • Full-year 2025 group sales guidance narrowed to €20.8–21.4 billion, midpoint €21.1 billion; organic net sales growth guidance at ~3%.

  • EBITDA pre guidance narrowed to €6–6.2 billion, midpoint €6.1 billion; organic EBITDA pre growth now 5–10%.

  • EPS pre guidance raised to €8.20–8.60.

  • Healthcare organic sales growth expected at ~3%, with SpringWorks portfolio effect raised to €180 million in sales.

  • Electronics organic sales development forecast at -3% to -1%.

  • For 2026, group sales expected at lower end of prior range; group margin targeted at ~28% to mitigate Mavenclad US erosion.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Merck earnings date

Logotype for Merck KGaA
Q4 20255 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Merck earnings date

Logotype for Merck KGaA
Q4 20255 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. The company's Life Science business segment focuses on the development, manufacture, marketing and distribution of pharmaceutical products. It offers drugs for a range of therapeutic indications from central nervous system diseases to cardiovascular and metabolic disorders. In addition to its own pharmaceutical activities, MERCK helps develop medicines for customers. The company also participates in the development of active substances with partners.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage